BeStock  
Markets › Compare › CORT vs PTGX

CORT vs PTGX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CORT · Corcept Therapeutics$63.62 ▼ 2.09%
PTGX · Protagonist Therapeutics$121.40 ▼ 2.11%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3372111150189Nov 24, '25May 26, '26Nov 20, '26
  • CORT -18.1%
  • PTGX +38.4%

Head to head

MetricCORTPTGX
Price$63.62$121.40
Change today▼ 2.09%▼ 2.11%
Market cap$6.96B$7.92B
Return, 3 months-48.4%-21.5%
Return, year to date+82.8%+39.0%
Return, 1 year-17.7%+42.2%
P/E (TTM)47.825.7
P/B8.47.3
P/E percentile vs own 5y69th78th
Dividend yield––
Revenue growth (YoY, latest qtr)+64.0%+5,723.6%
Net profit growth (YoY)+544.6%+659.3%
Gross margin98.5%99.6%
Operating margin11.5%58.6%
Net margin16.5%62.0%
Return on equity21.7%39.6%
Analyst target vs. price+161.4%+48.3%
Analyst buy share100%100%
RSI (14)2132
30-day volatility78.5%41.1%
Max drawdown, 1 year-63.5%-23.5%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • PTGX is the largest of the group by market value.
  • PTGX has returned the most over the past year.
  • PTGX carries the lowest trailing P/E.
  • PTGX is growing revenue fastest.
  • PTGX keeps the most profit per dollar of sales.
  • PTGX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top